atiprimod

{
  "id": "MLC-T-ONC-000785",
  "term": "atiprimod",
  "field": "Oncology and biomedicine",
  "definitions": [
    "A substance being studied in the treatment of certain multiple myelomas and other advanced cancers. Atiprimod may block the growth of tumors and may prevent the growth of new blood vessels that tumors need to grow. Atiprimod is a type of signal transduction inhibitor and a type of antiangiogenesis agent. Also called azaspirane and SK&F106615.",
    "An orally bioavailable small molecule belonging to the azaspirane class of cationic amphiphilic agents with anti-inflammatory, antineoplastic, and antiangiogenic properties. Atiprimod inhibits the phosphorylation of signal transducer and activator of transcription 3 (STAT3), blocking the signalling pathways of interleukin-6 and vascular endothelial growth factor (VEGF) and downregulating the anti-apoptotic proteins Bcl-2, Bcl-XL, and Mcl-1, thereby inhibiting cell proliferation, inducing cell cycle arrest, and inducing apoptosis."
  ],
  "synonyms": [
    "azaspirane",
    "SK&F106615",
    "azaspirane SK&F106615"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/atiprimod/"
}